The Discounted Cash Flow (DCF) valuation of NGM Biopharmaceuticals Inc (NGM) is (58.33) USD. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on DCF is -3887.8%.
Based on the latest price of 1.54 USD and our DCF valuation, NGM Biopharmaceuticals Inc (NGM) is a sell. selling NGM stocks now will result in a potential gain of 3887.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.3% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (365.04) - (32.66) | (58.33) |
| Upside | -23803.9% - -2220.6% | -3887.8% |